VPIM
RMD icon

Vanguard Personalized Indexing Management’s ResMed RMD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.28M Sell
27,963
-1,327
-5% -$331K 0.06% 268
2025
Q4 		$7.06M Sell
29,290
-1,241
-4% -$317K 0.07% 235
2025
Q3 		$8.36M Sell
30,531
-199
-0.6% -$54.4K 0.09% 196
2025
Q2 		$7.93M Buy
30,730
+4,424
+17% +$1.06M 0.09% 191
2025
Q1 		$5.89M Buy
26,306
+2,301
+10% +$537K 0.09% 202
2024
Q4 		$5.49M Buy
24,005
+648
+3% +$156K 0.08% 203
2024
Q3 		$5.7M Buy
23,357
+2,769
+13% +$619K 0.09% 188
2024
Q2 		$3.89M Buy
20,588
+2,175
+12% +$441K 0.07% 231
2024
Q1 		$3.65M Buy
18,413
+715
+4% +$131K 0.08% 227
2023
Q4 		$3.04M Buy
17,698
+10,074
+132% +$1.55M 0.08% 236
2023
Q3 		$1.13M Buy
7,624
+252
+3% +$45.6K 0.03% 505
2023
Q2 		$1.61M Sell
7,372
-98
-1% -$21.8K 0.05% 370
2023
Q1 		$1.64M Buy
7,470
+233
+3% +$50.5K 0.06% 350
2022
Q4 		$1.51M Sell
7,237
-3,549
-33% -$780K 0.06% 354
2022
Q3 		$2.35M Buy
10,786
+2,392
+28% +$544K 0.11% 190
2022
Q2 		$1.76M Buy
8,394
+2,456
+41% +$523K 0.08% 243
2022
Q1 		$1.44M Buy
5,938
+2,188
+58% +$529K 0.07% 280
2021
Q4 		$977K Buy
3,750
+657
+21% +$170K 0.06% 402
2021
Q3 		$815K Buy
3,093
+536
+21% +$147K 0.07% 291
2021
Q2 		$630K Buy
2,557
+1,056
+70% +$222K 0.07% 383
2021
Q1 		$291K Sell
1,501
-65
-4% -$13K 0.04% 516
2020
Q4 		$333K Buy
1,566
+230
+17% +$45.9K 0.07% 330
2020
Q3 		$229K Buy
+1,336
New +$247K 0.06% 367

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vanguard Personalized Indexing Management's RMD Position: Q1 2026 in Review

Vanguard Personalized Indexing Management reduced its ResMed (RMD) stake by 4.5% in Q1 2026, selling an estimated $331K and leaving 27,963 shares worth $6.28M. The position accounts for 0.06% of the portfolio, ranked #268.

Vanguard Personalized Indexing Management first reported a position in RMD in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.36M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Vanguard Personalized Indexing Management held 27,963 shares of ResMed worth $6.28M as of Q1 2026.
  • Vanguard Personalized Indexing Management sold 1,327 ResMed shares in Q1 2026, an estimated $331K.
  • ResMed made up 0.06% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #268 holding.
  • Vanguard Personalized Indexing Management first reported a position in ResMed in Q3 2020 and has held it in 23 quarters since.
  • Vanguard Personalized Indexing Management's ResMed position peaked at $8.36M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.